Harrow Health Net Worth
Harrow Health Net Worth Breakdown | HROWL |
Harrow Health Net Worth Analysis
Harrow Health's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Harrow Health's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Harrow Health's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Harrow Health's net worth analysis. One common approach is to calculate Harrow Health's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Harrow Health's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Harrow Health's net worth. This approach calculates the present value of Harrow Health's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Harrow Health's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Harrow Health's net worth. This involves comparing Harrow Health's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Harrow Health's net worth relative to its peers.
Enterprise Value |
|
To determine if Harrow Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Harrow Health's net worth research are outlined below:
| The company reported the revenue of 130.19 M. Net Loss for the year was (24.41 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| On 31st of January 2025 Harrow Health paid $ 0.5391 per share dividend to its current shareholders | |
| Latest headline from MacroaxisInsider: Acquisition by Opaleye Management Inc. of 1343 shares of Harrow Health at 6.8873 subject to Rule 16b-3 |
Harrow Health Quarterly Good Will |
|
Follow Harrow Health's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 247.48 M.Market Cap |
|
Project Harrow Health's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.16) | (0.15) | |
| Return On Assets | (0.07) | (0.07) | |
| Return On Equity | (0.31) | (0.33) |
When accessing Harrow Health's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Harrow Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Harrow Health's profitability and make more informed investment decisions.
Evaluate Harrow Health's management efficiency
Return On Capital Employed is expected to rise to 0 this year, although the value of Return On Tangible Assets are projected to rise to (0.15). At this time, Harrow Health's Intangibles To Total Assets are quite stable compared to the past year. Fixed Asset Turnover is expected to rise to 11.94 this year, although the value of Net Tangible Assets will most likely fall to about 1.2 M. Harrow Health's management efficiency ratios could be used to measure how well Harrow Health manages its routine affairs as well as how well it operates its assets and liabilities.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 2.48 | 2.13 | |
| Tangible Book Value Per Share | (3.24) | (3.08) | |
| Enterprise Value Over EBITDA | 44.59 | 46.82 | |
| Price Book Value Ratio | 5.94 | 11.43 | |
| Enterprise Value Multiple | 44.59 | 46.82 | |
| Price Fair Value | 5.94 | 11.43 | |
| Enterprise Value | 433.6 M | 455.2 M |
Effective management at Harrow Health has been a driving force behind its market achievements. We assess the correlation between management practices and financial success to determine the stock's value.
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Harrow Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Harrow Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Harrow Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Harrow Health Corporate Filings
F4 | 20th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 17th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 8th of January 2025 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
13A | 5th of December 2024 An amended filing to the original Schedule 13G | ViewVerify |
Harrow Health Earnings per Share Projection vs Actual
When determining whether Harrow Health 8625 is a strong investment it is important to analyze Harrow Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Harrow Health's future performance. For an informed investment choice regarding Harrow Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health 8625. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. For more information on how to buy Harrow Stock please use our How to buy in Harrow Stock guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harrow Health. If investors know Harrow will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harrow Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Harrow Health 8625 is measured differently than its book value, which is the value of Harrow that is recorded on the company's balance sheet. Investors also form their own opinion of Harrow Health's value that differs from its market value or its book value, called intrinsic value, which is Harrow Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harrow Health's market value can be influenced by many factors that don't directly affect Harrow Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harrow Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harrow Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harrow Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.